Join our team

The LIT – Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu/) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.

The Immune Monitoring Facility is recruiting a highly motivated

Staff Scientist (Postdoc) (m/f/d) – MX-2026-1

(full time, 40.1 hours per week)

The position is initially limited to two years with the possibility of extension.

The Immune Monitoring Facility provides various immunological analysis techniques, both cellular and molecular, for the characterization of the frequency, phenotype, and function of immune cells through all phases of a clinical study – from the initial idea to its completion. The facility has a strong translational focus on novel cell therapy studies, particularly those using CAR- and TCR-genetically modified T cells. In this context, the laboratory employs GLP/GCP-compliant procedures for sample collection, cryopreservation, and storage but also Standard Operating Procedures (SOPs) and validated analytical platforms for patient sample analysis in clinical trials. These include multi-parametric flow cytometry, functional T cell assays, cytokine release readouts, real-time qPCR, advanced single-cell genomic approaches and in situ single-cell protein expression analysis.The successful candidate will contribute to the development, optimization, and standardization of these methodologies and their application for sample analysis to support ongoing and future clinical studies.

Your tasks include, but are not limited to:
• Design, perform, analyze and interpret established immunomonitoring assays on experimental and clinical samples
• Establish, optimize, standardize and validate immunomonitoring assays and workflows
• Set up and implement new technologies and assays
• Contribute to quality management, assay validation, SOPs, and accreditation-related activities and documentation
• Train and provide guidance to technicians and junior colleagues
• Collaborate with technicians, researchers and clinicians in an interdisciplinary environment
• Contribute to presentations, scientific reports, manuscript preparation and grant applications

The ideal candidate possesses:
• PhD in Immunology, Biomedical Sciences, Cell Biology, Molecular Biology or a closely related discipline.
• Strong background in Immunology and T cell biology.
• Proven hands-on experience with advanced multicolor flow cytometry, including panel design, sample preparation, manual compensation, data analysis, interpretation and visualization.
• Experience in T-cell functional assays (antigen-specific stimulation, cytotoxicity assays) and cytokine secretion analysis (ELISA).
• Advanced command of molecular biology techniques (DNA/RNA isolation, real-time qPCR)
• Strong analytical, organizational and communication skills.
• Focus on precise protocol implementation and high-quality data generation.
• High self-motivation with an intrinsic service mentality, a collaborative attitude and the drive to advance the translational pipeline of the institute.
• Excellent oral and written communication skills in English
• Interest in working in an interdisciplinary and international environment
• Experience with FACS sorting, single-cell sequencing or Immunofluorescence and familiarity with quality management systems and assay validation is an advantage.

We offer:
• An international cutting-edge research environment that offers exciting and diverse opportunities
• Flat hierarchies and short decision-making processes
• A highly motivated and cooperative team
• Flexible working hours
• Job ticket and excellent benefits
• Excellent funding situation and state-of-the-art equipment

The remuneration is based on TV-L.

The Leibniz Institute for Immunotherapy aims to increase the share of women in the workforce. Therefore, qualified female candidates are explicitly encouraged to submit their applications. Moreover, the LIT advocates for the compatibility of family and career.

Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.

Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.

For more information, please contact Dr. Maria Xydia (maria.xydia@lit.eu).

We are looking forward to receiving your detailed application. Please apply via our Online – Application Portal quoting the reference MX-2026-1.

Application deadline is September the 6th, 2026.

The LIT – Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.

The Experimental Cell Therapy at the LIT is recruiting a

PhD position (m/f/d) – VE-2026-1

Starting November 1st, 2026. The position is initially limited to three years, with the possibility of extension.

About the project
The Vander Mause Lab, Experimental Cell Therapy, is seeking a PhD student (m/f/div) with a background in cell therapy or immunology. The candidate will use comprehensive multi-omics data to guide state-of-the-art methods in protein design and genetic engineering to develop and characterize the next generation of precision cell therapies for clinical translation.
The Experimental Cell Therapy lab is part of the Systems Rheumatology program area at the DRFZ in Berlin and is a joint research group with the Leibniz Institute for Immunotherapy (LIT) in Regensburg, Germany. This PhD position will be integrated into the doctoral environment at the DRFZ in Berlin, which has its own graduate program and access to partner programs. The program brings together like-minded PhD students from across Berlin and offers a variety of graduate training programs and events.
The German Rheumatology Research Center (DRFZ), an Institute of the Leibniz Association, was founded in 1988 and is unique in Germany in its focus on rheumatic diseases. Today, the DRFZ ranks among the world’s leading institutes in the fields of immunology, experimental rheumatology and the epidemiology of rheumatic diseases. The unique interdisciplinary collaboration among experts in biology, biotechnology, bioinformatics, chemistry, physics, medicine, sociology, and statistics is a key factor in this. The research focuses on the causes, progression, and management of rheumatic diseases.

Your profile:
• M.D and/or MSc in immunology, cell biology, bioinformatics, biochemistry, or similar.
• Experience preferred in cell culture (primary T cell culture preferred), molecular biology, viral production, and protein expression, purification, and characterization techniques.
• Bioinformatics and sequencing experience is a plus.
• Organizational skills, willingness to learn, and enthusiasm for science.
• Fluent in English.

We offer:
• An international cutting-edge research environment that offers exciting and diverse opportunities
• Perspectives for further scientific qualification
• Flexible working hours
• Flat hierarchies and short decision-making processes
• A highly motivated and cooperative team
• Possibility to enroll in the RIGeL graduate school
• Company pension scheme (VBL)
• Annual special payment
• Capital-forming benefits
• Job ticket and more

The remuneration is based on TV-L (E13, 65%).

The LIT places particular emphasis on promoting a healthy work-life balance.

Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.

Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.

For more information, please contact Dr. Erica Vander Mause (erica.vander-mause@lit.eu).

We are looking forward to receiving your detailed application. Please apply via our Online – Application Portal quoting the reference VE-2026-1.

The application deadline is September 1st , 2026.

The LIT – Leibniz Institute for Immunotherapy (foundation under civil law) (https://lit.eu) – is a biomedical research center focusing on translational immunology in the fields of cancer immunotherapy, transplant rejection and autoimmunity. The objective of the LIT is to develop innovative and efficient cellular immune therapeutics in these areas. Our own GMP laboratories and close networking with University and University Hospital offer excellent opportunities for clinical translation of novel immune cell products.

The Division of Immunology at the LIT is recruiting a

PhD position (m/f/d) – MF-2026-2

Starting as soon as possible. The position is initially limited to three years, with the possibility of extension.

About the project
The position is part of a team that studies T cells and how they influence tissue biology. Regulatory T cells (Treg cells) are a prototype subset involved in tissue biology, supporting tissue homeostasis and repair.
CD8⁺ T cells are classically known for their cytotoxic activity against infected or malignant cells. Increasing evidence, however, indicates that they also participate in tissue repair and remodeling. Distinct CD8⁺ T cell subsets can secrete cytokines and growth factors linked to regenerative processes.
We offer a PhD position addressing the role of CD8 T cells in tissue remodeling and repair in the context of autoimmunity and cancer.

Your tasks:
• Design and perform experiments to analyze CD8 tissue biology in disease models
• Characterize the phenotype of tissue CD8 T cells including single cell sequencing technologies
• Genetically modify CD8 T cells
• Use cellular methods (e.g., FACS) and functional assays (cytotoxicity assays, ELISA, 3D organoids, imaging, etc.) to characterize CD8 T cells
• Perform in vivo experiments
• Write/publish scientific manuscripts

Your profile:
• Master’s degree in biology/molecular medicine or related fields, with a strong background in immunology
• Creative mind that is eager to shape the project and who wants to make an important impact on immunological and biomedical research
• Experimental training in molecular biology and immunology, in particular working with T cells
• Hands-on experience in multi-color flow cytometry
• Excellent oral and written communication skills in English
• Experience in mouse models (FELASA certificate) would be advantageous

We offer:
• An international cutting-edge research environment that offers exciting and diverse opportunities
• Perspectives for further scientific qualification
• Flexible working hours
• Flat hierarchies and short decision-making processes
• A highly motivated and cooperative team
• Possibility to enroll in the RIGeL graduate school
• Company pension scheme (VBL)
• Annual special payment
• Capital-forming benefits
• Job ticket and more

The remuneration is based on TV-L (E13, 65%).

The LIT places particular emphasis on promoting a healthy work-life balance.

Disabled applicants (m/f/d) with equal qualifications will receive preferential treatment within the recruitment procedure. Please refer to your disability status already in your application.

Please note that expenses that may arise in the context of an eventual job interview cannot be reimbursed.

For more information, please contact Prof Dr. Markus Feuerer (markus.feuerer@lit.eu).

We are looking forward to receiving your detailed application. Please apply via our Online – Application Portal quoting the reference MF-2026-2.

The application deadline is September 06th, 2026.

Das LIT – Leibniz-Institut für Immuntherapie (Stiftung des bürgerlichen Rechts) erforscht und entwickelt neue Immuntherapien zur Behandlung von Tumoren, Autoimmunerkrankungen und Transplantatabstoßungen.

Die Verwaltung sucht zum nächstmöglichen Zeitpunkt einen

Bilanzbuchhalter (m/w/d) – Verw-2026-3

in Vollzeit (40,01 Stunden pro Woche), unbefristet

Hauptaufgaben:
• Organisation und Bearbeitung der laufenden Geschäftsvorfälle
• Erstellung von Auswertungen, Statistiken und Umsatzsteuervoranmeldungen
• Erstellung des Jahresabschlusses nach HGB
• Vorbereitung der betrieblichen Jahressteuererklärungen
• Ansprechpartner für Wirtschaftsprüfer und Steuerberater
• Kommunikation und Abstimmung mit den Fachabteilungen
• Mitwirkung bei der Optimierung von Verwaltungsprozessen

Anforderungen:
• Erfolgreich abgeschlossene kaufmännische Ausbildung mit Weiterbildung zum
Bilanzbuchhalter (w/m/d) oder vergleichbare Fähigkeiten und Erfahrungen
• Mehrjährige Berufserfahrung im Bereich der Buchhaltung und Bilanzierung
• Sicherer Umgang mit ERP-Systemen
• Sehr gutes Ausdrucksvermögen in der deutschen Sprache, gute Englischkenntnisse
• Gute Anwenderkenntnisse in MS Office
• Hohes Maß an Organisations- und Kommunikationsgeschick
• Flexibilität hinsichtlich des Einsatzes auch in anderen Verwaltungsbereichen

Wir bieten:
• Verantwortungsvolles und abwechslungsreiches Aufgabengebiet
• Gründliche Einarbeitung
• Flache Hierarchien und kurze Entscheidungswege
• Ein hoch motiviertes und kollegiales Team
• Exzellente fachliche und persönliche Weiterentwicklung
• Flexible Arbeitszeiten zur Vereinbarkeit von Familie und Beruf
• Betriebliche Altersvorsorge (VBL)
• Jahressonderzahlung
• Vermögenswirksame Leistungen
• Jobticket u.v.m.

Die Vergütung erfolgt nach TV-L.

Das LIT setzt sich besonders für die Vereinbarkeit von Familie und Beruf ein.

Schwerbehinderte (m/w/d) werden bei ansonsten im Wesentlichen gleicher Eignung bevorzugt eingestellt. Bitte weisen Sie auf eine vorliegende Schwerbehinderung in der Bewerbung hin.

Bitte beachten Sie, dass wir Kosten, die bei einem etwaigen Vorstellungsgespräch für Sie anfallen sollten, nicht übernehmen können.

Bei Rückfragen wenden Sie sich bitte an die kaufmännische Direktorin Frau Brigitte Herbst (brigitte.herbst@lit.eu).

Wir freuen uns auf Ihre ausführliche Bewerbung.

Bitte bewerben Sie sich über den Link unter Nennung der Kennung Verw-2026-3 bis 16.08.2026.

Die Stiftung Leibniz-Institut für Immuntherapie (LIT) erforscht und entwickelt neue Immuntherapien zur Behandlung von Tumoren, Autoimmunerkrankungen und Transplantatabstoßungen.

Für das GMP-Labor des Leibniz-Institut für Immuntherapie (Josè-Carreras-Centrum für Somatische Zelltherapie – JCC) suchen wir ab sofort einen

MTA, BTA, PTA oder CTA m/w/d – ME-2026-1

in Vollzeit (40,1 Stunden pro Woche). Die Stelle ist zunächst befristet auf zwei Jahre mit der Möglichkeit der Weiterbeschäftigung.

Das JCC (José-Carreras-Centrum) ist ein modernes Reinraumlaborgebäude zur GMP-konformen Herstellung von Stammzellpräparaten und neuartigen Zelltherapeutika zur Behandlung von Patienten im Rahmen von klinischen Studien.

Hauptaufgaben:
• Aseptische Herstellung zellbasierter Arzneimittel im Reinraum
• Durchführung von Prüfungen an zellbasierten Arzneimitteln
• Durchflusszytometrische Analysen von Patientenproben
• GMP-gerechte Dokumentation der Tätigkeiten
• Überwachung und Instandhaltung von Geräten, Anlagen und Produktionsräumen
• Mitarbeit bei der Erstellung von Arbeitsanweisungen, Herstell- und Prüfvorschriften
• Mitarbeit bei Prozessentwicklungen

Anforderungen:
• Abgeschlossene Berufsausbildung als Technischer Assistent
• Interesse am Qualitätsmanagement
• Hohes Maß an Eigenverantwortung
• Gewissenhafter und präziser Arbeitsstil
• Bereitschaft zur ständigen Weiterbildung
• Gute Deutschkenntnisse in Wort und Schrift

Es erwartet Sie ein sympathisches und dynamisches Team, das mit besonderem Engagement und viel Eigenverantwortung an der Entwicklung und klinischen Prüfung innovativer Zelltherapeutika arbeitet. Die Herstellung und Prüfung von zellbasierten Arzneimitteln verlangt die exakte Einhaltung gesetzlicher und regulatorischer Vorgaben, weshalb ein präziser Arbeitsstil erforderlich ist. Die Brückenfunktion des JCC zwischen Grundlagenforschung und klinischer Translation erfordert Kreativität und bietet eine verantwortungsvolle und abwechslungsreiche Tätigkeit in einem akademischen Umfeld.

Wir bieten:
• Verantwortungsvolles und abwechslungsreiches Aufgabengebiet
• Gründliche Einarbeitung
• Flache Hierarchien und kurze Entscheidungswege
• Ein hoch motiviertes und kollegiales Team
• Exzellente fachliche und persönliche Weiterentwicklung
• Flexible Arbeitszeiten zur Vereinbarkeit von Familie und Beruf
• Betriebliche Altersvorsorge (VBL)
• Jahressonderzahlung
• Vermögenswirksame Leistungen
• Jobticket u.v.m.

Die Vergütung erfolgt nach TV-L.

Das LIT setzt sich besonders für die Vereinbarkeit von Familie und Beruf ein.

Schwerbehinderte (m/w/d) werden bei ansonsten im Wesentlichen gleicher Eignung bevorzugt eingestellt. Bitte weisen Sie auf eine vorliegende Schwerbehinderung in der Bewerbung hin.

Bitte beachten Sie, dass wir Kosten, die bei einem etwaigen Vorstellungsgespräch für Sie anfallen sollten, nicht übernehmen können.

Bei Rückfragen wenden Sie sich bitte an Herrn Prof. Dr. Matthias Edinger (Tel.: 0941/944-5582, matthias.edinger@ukr.de).

Wir freuen uns auf Ihre ausführliche Bewerbung.

Bitte bewerben Sie sich über unser Bewerbungsportal oder unsere Homepage https://lit.eu unter der Kennung ME-2026-1 bis 16.08.2026

At the Leibniz Institute for Immunotherapy, we believe that talent and passion know no bounds. If you don’t see a position that matches your skills and ambitions among our current openings, we encourage you to submit an unsolicited application. We are always on the lookout for motivated and talented individuals who can contribute to our mission and help drive our success.